By using this website you allow us to place cookies on your computer. Please read our Privacy Policy for more details.
Publication Date: August 2003
Publisher: Library of Congress. Congressional Research Service
Author(s):
Research Area: Law and ethics
Type:
Abstract:
The U.S. government and private firms alike seek high technology solutions to detect and prevent future terrorist attacks, as well as to respond to any future attacks that do occur. Some concerns exist, however, that patents, trade secrets or other intellectual rights may impede the prompt, widespread and cost-effective distribution of innovations that promote homeland security. These concerns recently arose with respect to pharmaceutical CIPRO, and antibiotic that tread inhalation anthrax. Some commentators called for the U.S. government to “override†a privately owned patent in order to distribute CIPRO to persons who were potential anthrax victims. Although the patent holder ultimately chose to increase production of CIPRO and lower costs, this scenario remains a possibility for other technologies that bear upon homeland security.